Nymox Pharmaceutical Corp (NYMX) Earnings
|
Expand Research on NYMX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/14/23 | Q223 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/15/23 | Q123 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/17/23 | Q422 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/16/22 | Q322 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/15/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/22/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/29/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/15/15 | Q115 | $0.04 | N/A | N/A | $75.4K | $78.2K | N/A |  | | Details |
